Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07968101000 Ext: 1 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
Profit before tax stood at Rs 186.09 crore in Q4 FY25, up 124.17% as against Rs 83.01 crore recorded in Q4 FY24.
The company's total expenses increased 14.87% YoY to Rs 1,315.84 crore during the quarter. Cost of materials consumed stood at Rs 709.42 crore (up 16.03% YoY) and employee benefit expenses stood at Rs 118.87 crore (up 16.02% YoY) during the period under review.
On segmental front, revenue from life science chemicals was at Rs 443.89 crore (up 17.84% YoY) and revenue from performance and other chemicals was at Rs 1,054.72 crore (up 21.28% YoY), during the quarter.
On a full-year basis, the company's consolidated net profit soared 49.81% to Rs 483.93 crore on 18.14% rise in revenue to Rs 5,583.35 crore in FY25 over FY24.
Meanwhile, the company's board has proposed a dividend of Rs 25 per equity share for the year ended 31 March 2025 which is subject to approval of the members at the ensuing annual general meeting (AGM) to be held on 25 July 2025.
Atul has one of the biggest integrated chemical complexes in India with a well-diversified product portfolio of around 900 products and 400 formulations. Geographically, its sales are almost evenly distributed between domestic and exports. It has marketing offices through its subsidiaries in USA, UK, Germany, UAE, China, Brazil, etc.
Powered by Capital Market - Live News